Colorectal cancer is the third most common cancer in the United States. Although screening has led to a decrease in incidence ...

The U.S. Food and Drug Administration (FDA) has granted traditional approval to Braftovi (encorafenib) for adult patients ...

Project Cure CRC has invested nearly $13 million in 32 groundbreaking studies, with several findings published in leading scientific journals. The initiative supports innovative research, including ...

For years, a diagnosis of colon cancer meant potential surgery followed by a painful round of chemotherapy to kill the remaining cancer cells. One-size-fits-all treatment was normal. A new blood test ...

Colorectal Cancer Alliance Urges Action through Project Cure CRC The Alliance is prepared to meet this moment and ...

New England Cancer Specialists emphasizes that colorectal cancer symptoms can be nonspecific and easy to dismiss.

Doctors want you to keep these symptoms in mind.

It might be time to rethink that little pill in your medicine cabinet. A new study casts doubt on the idea that regularly ...

MD Anderson is launching a dedicated colorectal center designed to bring multiple specialties together in one place, with ...

In 2026, an estimated 158,850 new cases of colorectal cancer (CRC) will be diagnosed, and 55,230 people will die from the ...

The face of colorectal cancer is getting younger by the day. Meanwhile, researchers are potentially years away from understanding why. Just weeks after actor James Van Der Beek died of colorectal ...

Developing assertiveness is portrayed as a protective shift from people-pleasing and emotional suppression toward clearer ...